Axsome Therapeutics
Stock Forecast, Prediction & Price Target
Axsome Therapeutics Financial Estimates
Axsome Therapeutics Revenue Estimates
Axsome Therapeutics EBITDA Estimates
Axsome Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $50.03M 0% | $270.6M 440.79% | Avg: $671.48M Low: $671.48M High: $671.48M avg. 148.14% | Avg: $1.11B Low: $1.11B High: $1.11B avg. 66.17% | Avg: $1.56B Low: $1.56B High: $1.56B avg. 40.04% | Avg: $2.04B Low: $2.04B High: $2.04B avg. 30.55% |
Net Income
% change YoY
| $-134.94M N/A | $-197.76M -46.55% | $-239.23M -20.96% | Avg: $-6.13M Low: $-6.13M High: $-6.13M avg. 97.43% | Avg: $284.29M Low: $284.29M High: $284.29M avg. 4734.61% | Avg: $556.58M Low: $556.58M High: $556.58M avg. 95.77% | Avg: $758.34M Low: $758.34M High: $758.34M avg. 36.24% |
EBITDA
% change YoY
| $-124.70M N/A | $-170.93M -37.07% | $-224.99M -31.62% | Avg: $181.21M Low: $181.21M High: $181.21M avg. 180.54% | Avg: $301.13M Low: $301.13M High: $301.13M avg. 66.17% | Avg: $421.72M Low: $421.72M High: $421.72M avg. 40.04% | Avg: $550.60M Low: $550.60M High: $550.60M avg. 30.55% |
EPS
% change YoY
| -$3.59 N/A | -$4.86 -35.37% | -$5.27 -8.43% | Avg: -$0.14 Low: -$0.14 High: -$0.14 avg. 97.43% | Avg: $6.26 Low: $6.26 High: $6.26 avg. 4734.61% | Avg: $12.25 Low: $12.25 High: $12.25 avg. 95.77% | Avg: $16.69 Low: $16.69 High: $16.69 avg. 36.24% |
Operating Expenses
% change YoY
| $124.70M N/A | $221.34M 77.48% | $476.36M 115.21% | Avg: $990.68M Low: $990.68M High: $990.68M avg. 107.97% | Avg: $1.64B Low: $1.64B High: $1.64B avg. 66.17% | Avg: $2.30B Low: $2.30B High: $2.30B avg. 40.04% | Avg: $3.01B Low: $3.01B High: $3.01B avg. 30.55% |
FAQ
What is Axsome Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 1241.01% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -6.13M, average is -6.13M and high is -6.13M.
What is Axsome Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 71.23% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $671.48M, average is $671.48M and high is $671.48M.
What is Axsome Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 1241.01% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.14, average is -$0.14 and high is $-0.13.